Page last updated: 2024-08-21

cyclopentane and apcin

cyclopentane has been researched along with apcin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dai, X; Ding, Q; Gan, W; Li, M; Mitsiades, N; Wan, L; Wei, W; Wu, F; Zhang, J	1

Other Studies

1 other study(ies) available for cyclopentane and apcin

Article	Year
Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation. Cancer letters, 2017, 01-28, Volume: 385 Topics: Antineoplastic Agents; Carbamates; Cdc20 Proteins; Cullin Proteins; Cyclopentanes; Diamines; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; HeLa Cells; Humans; Male; Molecular Targeted Therapy; Mutation; Nuclear Proteins; Prostatic Neoplasms; Protein Interaction Domains and Motifs; Proteolysis; Pyrimidines; Repressor Proteins; Time Factors; Transfection; Ubiquitination	2017

Article

Year

Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation.

Cancer letters, 2017, 01-28, Volume: 385

Topics: Antineoplastic Agents; Carbamates; Cdc20 Proteins; Cullin Proteins; Cyclopentanes; Diamines; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; HeLa Cells; Humans; Male; Molecular Targeted Therapy; Mutation; Nuclear Proteins; Prostatic Neoplasms; Protein Interaction Domains and Motifs; Proteolysis; Pyrimidines; Repressor Proteins; Time Factors; Transfection; Ubiquitination

2017